aTYR PHARMA (ATYR) Receivables - Other (2019 - 2026)
aTYR PHARMA's Receivables - Other came in at $426,000 for Q2 2026, down 14.5% from $498,000 a year earlier and down 10.7% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Receivables - Other (2019 - 2026) Analysis & Trends
At the end of FY2025, aTYR PHARMA's Receivables - Other was $873,000, down 49.7% from FY2024.
- Receivables - Other has declined in each of the last three years, with a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
- Going back by year, Receivables - Other was $1.74 million in FY2024 (-28.7%), $2.44 million in FY2023 (-79.3%), $11.78 million in FY2022 and $435,000 in FY2021 (-78.7%).
- The five-year range for quarterly Receivables - Other is $129,000 (Q3 2021) to $11.78 million (Q4 2022).
- Year-over-year, Receivables - Other has declined for eight consecutive quarters, with an average decline of 41.2% over the last eight quarters.
- The fastest year-over-year change in Receivables - Other over five years came in Q3 2022 (growth of 576.7%), and the weakest in Q4 2023 (a decline of 79.3%).
- Business Quant data shows ATYR's Receivables - Other at $477,000 (Q1 2026), $873,000 (Q4 2025) and $1.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | aTYR PHARMA | 16.81 Mn | -276.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 426,000.00 |
| Mar 31, 2026 | 477,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 498,000.00 |
| Mar 31, 2025 | 988,000.00 |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 11.78 Mn |
| Sep 30, 2022 | 873,000.00 |
| Jun 30, 2022 | 426,000.00 |
| Mar 31, 2022 | 426,000.00 |
| Dec 31, 2021 | 435,000.00 |
| Sep 30, 2021 | 129,000.00 |
API Access
aTYR PHARMA Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();